The Most Recent Insights into the Roots of Gastric Cancer

Helicobacter pylori (H. pylori) is the most common bacterial infection worldwide, usually being acquired during childhood, and its persistence into adulthood represents one of the main contributors of gastric carcinogenesis. Based on these statements, it would be of great importance to know if the most early premalignant transformation occurs in children or later since, this would enable the development of effective anti-tumorigenesis strategies. The interplay between H. pylori virulence factors, the host’s responses modified by this infection, and the gastric microecology are complex and eventually lead to the development of gastric cancer in susceptible individuals. Several biomarkers were identified as major contributors of this long-lasting process, such as pepsinogens, gastrin 17, lipid-, glucose- and iron-metabolism parameters, immunity players, aberrant bacterial DNA methylation, H. pylori virulence factors, and hallmarks of gastric dysbiosis. Several of these biomarkers were also identified in children with H. pylori infection, independently of the presence of premalignant lesions, which were also proven to be present in a subgroup of H. pylori-infected children, especially those carrying extremely virulent strains. Therefore, the most incipient premalignant gastric changes might indeed occur early during childhood, opening a promising research gate for further studies to delineate the border between infection and cancer.

[1]  F. Roviello,et al.  Postbiotics in oncology: science or science fiction? , 2023, Frontiers in microbiology.

[2]  Meiqin Yan,et al.  Circulating Proteins and Metabolite Biomarkers in Gastric Cancer: A Systematic Review and Meta-analysis. , 2023, Archives of medical research.

[3]  Jiayu Wang,et al.  Up-regulation of microRNA-183 reduces FOXO1 expression in gastric cancer patients with Helicobacter pylori infection. , 2023, Histology and histopathology.

[4]  C. Mărginean,et al.  Worldwide Prevalence and Risk Factors of Helicobacter pylori Infection in Children , 2022, Children.

[5]  S. Ding,et al.  Gastric mucosal precancerous lesions in Helicobacter pylori-infected pediatric patients in central China: A single-center, retrospective investigation , 2022, World journal of gastroenterology.

[6]  C. Mărginean,et al.  Old and New Aspects of H. pylori-Associated Inflammation and Gastric Cancer , 2022, Children.

[7]  M. Keikha,et al.  Clinical relevance of the cagA and vacA s1m1 status and antibiotic resistance in Helicobacter pylori: a systematic review and meta-analysis , 2022, BMC Infectious Diseases.

[8]  T. Attard,et al.  Gastric cancer in the pediatric population, a multicenter cross-sectional analysis of presentation and coexisting comorbidities , 2022, Journal of Cancer Research and Clinical Oncology.

[9]  Hsiao‐Bai Yang,et al.  Atrophic gastritis in Helicobacter pylori‐infected children , 2022, Helicobacter.

[10]  A. Belmouden,et al.  Potential Non-invasive Biomarkers of Helicobacter pylori-Associated Gastric Cancer , 2021, Journal of Gastrointestinal Cancer.

[11]  Hyunsoon Cho,et al.  Influence of Fasting Glucose Level on Gastric Cancer Incidence in a Prospective Cohort Study , 2021, Cancer Epidemiology, Biomarkers & Prevention.

[12]  A. Lagomarcino,et al.  Effect of Helicobacter pylori eradication therapy on clinical and laboratory biomarkers associated with gastric damage in healthy school‐aged children: A randomized non‐blinded trial , 2021, Helicobacter.

[13]  Alina Boglis,et al.  Innate immunity – the hallmark of Helicobacter pylori infection in pediatric chronic gastritis , 2021, World journal of clinical cases.

[14]  C. Mărginean,et al.  Gastric Microenvironment—A Partnership between Innate Immunity and Gastric Microbiota Tricks Helicobacter pylori , 2021, Journal of clinical medicine.

[15]  F. Chu,et al.  Serum pepsinogen II levels are doubled with Helicobacter pylori infection in an asymptomatic population of 40,383 Chinese subjects , 2021, Medicine.

[16]  Wenling Chen,et al.  Application of serum pepsinogen and carbohydrate antigen 72-4 (CA72-4) combined with gastrin-17 (G-17) detection in the screening, diagnosis, and evaluation of early gastric cancer. , 2021, Journal of gastrointestinal oncology.

[17]  T. Daniluk,et al.  Nanomechanical Hallmarks of Helicobacter pylori Infection in Pediatric Patients , 2021, International journal of molecular sciences.

[18]  J. Hasty,et al.  The microbiome and human cancer , 2021, Science.

[19]  L. Meliț,et al.  MicroRNA Modulation of Host Immune Response and Inflammation Triggered by Helicobacter pylori , 2021, International journal of molecular sciences.

[20]  M. Mahmoud,et al.  Human apoptosis antibody array-membranes studying the apoptotic effect of marine bacterial exopolysaccharides in HepG2 cells , 2021, Journal of cancer research and therapeutics.

[21]  A. Lagomarcino,et al.  Helicobacter pylori, clinical, laboratory and noninvasive biomarkers suggestive of gastric damage in healthy school-aged children: a case-control study. , 2020, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[22]  Ming-Wei Lin,et al.  NF-κB/miR-18a-3p and miR-4286/BZRAP1 axis may mediate carcinogenesis in Helicobacter pylori-Associated gastric cancer. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[23]  Nayoung Kim,et al.  Promising aberrant DNA methylation marker to predict gastric cancer development in individuals with family history and long-term effects of H. pylori eradication on DNA methylation , 2020, Gastric Cancer.

[24]  Qiong Wu,et al.  Recent advances of miRNAs in the development and clinical application of gastric cancer , 2020, Chinese medical journal.

[25]  J. Machlowska,et al.  Gastric Cancer: Epidemiology, Risk Factors, Classification, Genomic Characteristics and Treatment Strategies , 2020, International journal of molecular sciences.

[26]  L. Kupčinskas,et al.  Transient and Persistent Gastric Microbiome: Adherence of Bacteria in Gastric Cancer and Dyspeptic Patient Biopsies after Washing , 2020, Journal of clinical medicine.

[27]  R. Artigiani,et al.  The impact of DNA demethylation on the upregulation of the NRN1 and TNFAIP3 genes associated with advanced gastric cancer , 2020, Journal of Molecular Medicine.

[28]  W. El-Rifai,et al.  Bacterial CagA protein compromises tumor suppressor mechanisms in gastric epithelial cells. , 2020, The Journal of clinical investigation.

[29]  Yingwei Xue,et al.  Relationship between DLEC1 and PBX3 promoter methylation and the risk and prognosis of gastric cancer in peripheral blood leukocytes , 2020, Journal of Cancer Research and Clinical Oncology.

[30]  Meilin Wang,et al.  MUC1 is associated with TFF2 methylation in gastric cancer , 2020, Clinical Epigenetics.

[31]  A. Lagomarcino,et al.  Gastric Damage and Cancer-Associated Biomarkers in Helicobacter pylori-Infected Children , 2020, Frontiers in Microbiology.

[32]  Chaomin Wan,et al.  The relationship of gastric microbiota and Helicobacter pylori infection in pediatrics population , 2019, Helicobacter.

[33]  A. Szaflarska-Popławska,et al.  Relationship between Helicobacter pylori Infection and Plasmacytoid and Myeloid Dendritic Cells in Peripheral Blood and Gastric Mucosa of Children , 2019, Mediators of inflammation.

[34]  Ting Zhang,et al.  SIRT1-targeted miR-543 autophagy inhibition and epithelial–mesenchymal transition promotion in Helicobacter pylori CagA-associated gastric cancer , 2019, Cell Death & Disease.

[35]  Zhenhua Zhu,et al.  The eradication of Helicobacter pylori restores rather than disturbs the gastrointestinal microbiota in asymptomatic young adults , 2019, Helicobacter.

[36]  Xiaoli Ma,et al.  Discovery and validation of methylated-differentially expressed genes in Helicobacter pylori-induced gastric cancer , 2019, Cancer Gene Therapy.

[37]  E. Beierle,et al.  Pediatric gastric adenocarcinoma: A National Cancer Data Base review. , 2019, Journal of pediatric surgery.

[38]  W. Meng,et al.  Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer , 2019, World journal of gastroenterology.

[39]  Yuan Yuan,et al.  Development and validation of a prediction rule for estimating gastric cancer risk in the Chinese high-risk population: a nationwide multicentre study , 2019, Gut.

[40]  C. Mărginean,et al.  The Relationship between Toll-like Receptors and Helicobacter pylori-Related Gastropathies: Still a Controversial Topic , 2019, Journal of immunology research.

[41]  Mototsugu Kato,et al.  Serum Pepsinogen Values in Japanese Junior High School Students With Reference to Helicobacter Pylori Infection , 2019, Journal of epidemiology.

[42]  Huanbai Xu,et al.  LPS-induced CXCR7 expression promotes gastric Cancer proliferation and migration via the TLR4/MD-2 pathway , 2019, Diagnostic Pathology.

[43]  M. Capurro,et al.  VacA promotes CagA accumulation in gastric epithelial cells during Helicobacter pylori infection , 2019, Scientific Reports.

[44]  Mototsugu Kato,et al.  Gastric cancer in children and adolescents in Japan , 2019, Pediatrics international : official journal of the Japan Pediatric Society.

[45]  Y. Xiong,et al.  Analysis of culturable microbiota present in the stomach of children with gastric symptoms , 2018, Brazilian Journal of Microbiology.

[46]  Mai Kusakari,et al.  Clinical features of Helicobacter pylori antibody‐positive junior high school students in Nagano Prefecture, Japan , 2018, Helicobacter.

[47]  Zhijun Luo,et al.  Helicobacter pylori CagA promotes epithelial mesenchymal transition in gastric carcinogenesis via triggering oncogenic YAP pathway , 2018, Journal of Experimental & Clinical Cancer Research.

[48]  F. Arenas-Huertero,et al.  Differential expression of miRNA-146a and miRNA-155 in gastritis induced by Helicobacter pylori infection in paediatric patients, adults, and an animal model , 2018, BMC Infectious Diseases.

[49]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[50]  Z. Herceg,et al.  Genome‐wide profiling of normal gastric mucosa identifies Helicobacter pylori‐ and cancer‐associated DNA methylome changes , 2018, International journal of cancer.

[51]  W. El-Rifai,et al.  Helicobacter pylori‐induced miR‐135b‐5p promotes cisplatin resistance in gastric cancer , 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[52]  Shan Xu,et al.  MicroRNA-125a-5p inhibits invasion and metastasis of gastric cancer cells by targeting BRMS1 expression. , 2018, Oncology letters.

[53]  J. L. Costa,et al.  Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota , 2017, Gut.

[54]  J. Korlach,et al.  Genome and Methylome Variation in Helicobacter pylori With a cag Pathogenicity Island During Early Stages of Human Infection. , 2017, Gastroenterology.

[55]  Ryan M. O’Connell,et al.  Antitumor immunity is defective in T cell–specific microRNA-155–deficient mice and is rescued by immune checkpoint blockade , 2017, The Journal of Biological Chemistry.

[56]  A. Lagomarcino,et al.  Review: Prevalence and dynamics of Helicobacter pylori infection during childhood , 2017, Helicobacter.

[57]  R. Bostick,et al.  A Serological Biopsy Using Five Stomach-Specific Circulating Biomarkers for Gastric Cancer Risk Assessment: A Multi-Phase Study , 2017, American Journal of Gastroenterology.

[58]  Yong Xie,et al.  Overexpression of Tim-3 reduces Helicobacter pylori-associated inflammation through TLR4/NFκB signaling in vitro. , 2017, Molecular medicine reports.

[59]  P. Sham,et al.  Alterations in Gastric Microbiota After H. Pylori Eradication and in Different Histological Stages of Gastric Carcinogenesis , 2017, Scientific Reports.

[60]  F. Wang,et al.  MicroRNA-143-3p, up-regulated in H. pylori-positive gastric cancer, suppresses tumor growth, migration and invasion by directly targeting AKT2 , 2017, Oncotarget.

[61]  B. Marshall,et al.  Lipopolysaccharide Structure and Biosynthesis in Helicobacter pylori , 2016, Helicobacter.

[62]  Fumie 文恵 Ikeda 池田,et al.  Combination of Helicobacter pylori Antibody and Serum Pepsinogen as a Good Predictive Tool of Gastric Cancer Incidence: 20-Year Prospective Data From the Hisayama Study , 2016, Journal of epidemiology.

[63]  D. Graham,et al.  Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis. , 2016, Gastroenterology.

[64]  Sumio Watanabe,et al.  Comparison of Gene Expression Between Pediatric and Adult Gastric Mucosa with Helicobacter pylori Infection , 2016, Helicobacter.

[65]  Wei Liu,et al.  Association of TLR4 and Treg in Helicobacter pylori Colonization and Inflammation in Mice , 2016, PloS one.

[66]  A. Califano,et al.  High-definition CpG methylation of novel genes in gastric carcinogenesis identified by next-generation sequencing , 2016, Modern Pathology.

[67]  K. Rudnicka,et al.  Immunoregulation of antigen presenting and secretory functions of monocytic cells by Helicobacter pylori antigens in relation to impairment of lymphocyte expansion. , 2015, Acta Biochimica Polonica.

[68]  N. Kaakoush,et al.  Dual role of Helicobacter and Campylobacter species in IBD: a systematic review and meta-analysis , 2015, Gut.

[69]  Lei Ding,et al.  Dysregulation of non-coding RNAs in gastric cancer. , 2015, World journal of gastroenterology.

[70]  I. Meza,et al.  Helicobacter pylori CagA Suppresses Apoptosis through Activation of AKT in a Nontransformed Epithelial Cell Model of Glandular Acini Formation , 2015, BioMed research international.

[71]  T. Akamatsu,et al.  Screening to Identify and Eradicate Helicobacter pylori Infection in Teenagers in Japan. , 2015, Gastroenterology clinics of North America.

[72]  T. Pieber,et al.  Effects of high doses of vitamin D3 on mucosa-associated gut microbiome vary between regions of the human gastrointestinal tract , 2015, European Journal of Nutrition.

[73]  O. Ramilo,et al.  Persistent and transient Helicobacter pylori infections in early childhood. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[74]  P. Malfertheiner,et al.  Somatic DNA Hypomethylation in H. pylori-Associated High-Risk Gastritis and Gastric Cancer: Enhanced Somatic Hypomethylation Associates with Advanced Stage Cancer , 2015, Clinical and Translational Gastroenterology.

[75]  Hisao Tajiri,et al.  Plasma insulin, C‐peptide and blood glucose and the risk of gastric cancer: The Japan Public Health Center‐based prospective study , 2015, International journal of cancer.

[76]  Jeffrey L. Curtis,et al.  Analysis of the Upper Respiratory Tract Microbiotas as the Source of the Lung and Gastric Microbiotas in Healthy Individuals , 2015, mBio.

[77]  A. Moran,et al.  Helicobacter pylori-driven modulation of NK cell expansion, intracellular cytokine expression and cytotoxic activity , 2015, Innate immunity.

[78]  M. Plummer,et al.  Global burden of gastric cancer attributable to Helicobacter pylori , 2015, International journal of cancer.

[79]  D. Queiroz,et al.  CagA phosphorylation EPIYA-C motifs and the vacA i genotype in Helicobacter pylori strains of asymptomatic children from a high-risk gastric cancer area in northeastern Brazil , 2014, Memorias do Instituto Oswaldo Cruz.

[80]  K. Goh,et al.  Genetic polymorphisms in the Toll-like receptor signalling pathway in Helicobacter pylori infection and related gastric cancer. , 2014, Human immunology.

[81]  T. Shimosegawa,et al.  Novel role of toll-like receptors in Helicobacter pylori - induced gastric malignancy. , 2014, World journal of gastroenterology.

[82]  C. Staedel,et al.  MicroRNAs and bacterial infection , 2013, Cellular microbiology.

[83]  M. Ribeiro,et al.  Methylation Pattern of THBS1, GATA-4, and HIC1 in Pediatric and Adult Patients Infected with Helicobacter pylori , 2013, Digestive Diseases and Sciences.

[84]  P. Correa Gastric cancer: overview. , 2013, Gastroenterology clinics of North America.

[85]  P. Stattin,et al.  Prospective cohort study of metabolic risk factors and gastric adenocarcinoma risk in the Metabolic Syndrome and Cancer Project (Me-Can) , 2012, Cancer Causes & Control.

[86]  A. Montserrat,et al.  microRNA profiling in duodenal ulcer disease caused by Helicobacter pylori infection in a Western population. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[87]  P. Massari,et al.  The Role of TLR2 in Infection and Immunity , 2012, Front. Immun..

[88]  M. Piazuelo,et al.  The gastric precancerous cascade , 2012, Journal of digestive diseases.

[89]  T. Hirayama,et al.  Interweaving MicroRNAs and Proinflammatory Cytokines in Gastric Mucosa with Reference to H. pylori Infection , 2011, Journal of Clinical Immunology.

[90]  Howard C. Tenenbaum,et al.  Bacterial biogeography of the human digestive tract , 2011, Scientific reports.

[91]  T. Meyer,et al.  MicroRNA-155 Is Essential for the T Cell-Mediated Control of Helicobacter pylori Infection and for the Induction of Chronic Gastritis and Colitis , 2011, The Journal of Immunology.

[92]  S. Akira,et al.  Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. , 2011, Immunity.

[93]  T. Hirayama,et al.  MicroRNA signatures in Helicobacter pylori‐infected gastric mucosa , 2011, International journal of cancer.

[94]  M. Blaser,et al.  Serum Pepsinogens and Helicobacter pylori in Relation to the Risk of Esophageal Squamous Cell Carcinoma in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[95]  R. Peek,et al.  Role of innate immunity in Helicobacter pylori-induced gastric malignancy. , 2010, Physiological reviews.

[96]  J. Goldberg,et al.  Helicobacter pylori infection, oncogenic pathways and epigenetic mechanisms in gastric carcinogenesis. , 2010, Future oncology.

[97]  M. Rehli,et al.  Helicobacter pylori Lipopolysaccharides Upregulate Toll-Like Receptor 4 Expression and Proliferation of Gastric Epithelial Cells via the MEK1/2-ERK1/2 Mitogen-Activated Protein Kinase Pathway , 2009, Infection and Immunity.

[98]  M. Plebani,et al.  GastroPanel: evaluation of the usefulness in the diagnosis of gastro-duodenal mucosal alterations in children. , 2009, Clinica chimica acta; international journal of clinical chemistry.

[99]  N. Van Rooijen,et al.  Macrophages Are Mediators of Gastritis in Acute Helicobacter pylori Infection in C57BL/6 Mice , 2008, Infection and Immunity.

[100]  M. Kubo,et al.  Impact of serum total cholesterol on the incidence of gastric cancer in a population‐based prospective study: The Hisayama study , 2008, International journal of cancer.

[101]  G. Cavestro,et al.  Usefulness of a Serological Panel Test in the Assessment of Gastritis in Symptomatic Children , 2007, Digestive Diseases.

[102]  M. Oleastro,et al.  Relationship among serum pepsinogens, serum gastrin, gastric mucosal histology and H. pylori virulence factors in a paediatric population , 2006, Scandinavian journal of gastroenterology.

[103]  H. Müller-Hermelink,et al.  Toll-like receptors TLR4, TLR5 and TLR9 on gastric carcinoma cells: an implication for interaction with Helicobacter pylori. , 2005, International journal of medical microbiology : IJMM.

[104]  J. Goldberg,et al.  Toll‐like Receptor 2‐Mediated Gene Expression in Epithelial Cells During Helicobacter pylori Infection , 2005, Helicobacter.

[105]  Mark S. Sundrud,et al.  Inhibition of primary human T cell proliferation by Helicobacter pylori vacuolating toxin (VacA) is independent of VacA effects on IL-2 secretion. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[106]  M. D’Elios,et al.  The Helicobacter pylori Vacuolating Toxin Inhibits T Cell Activation by Two Independent Mechanisms , 2003, The Journal of experimental medicine.

[107]  R. Hunt,et al.  Meta-analysis of the relationship between cagA seropositivity and gastric cancer. , 2003, Gastroenterology.

[108]  R. Gillitzer,et al.  CXC chemokines Groα/IL‐8 and IP‐10/MIG in Helicobacter pylori gastritis , 2000 .

[109]  A. Terano,et al.  Redox Regulation of Interleukin-8 Expression in MKN28 Cells , 1999, Digestive Diseases and Sciences.

[110]  M F Dixon,et al.  Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. , 1996, The American journal of surgical pathology.

[111]  M. Blaser,et al.  Mosaicism in Vacuolating Cytotoxin Alleles of Helicobacter pylori , 1995, The Journal of Biological Chemistry.

[112]  M. Blaser,et al.  Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. , 1995, Cancer research.

[113]  A. Reunanen,et al.  Body iron stores and risk of cancer , 1994, International journal of cancer.

[114]  P. Correa,et al.  Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. , 1992, Cancer research.

[115]  Xia Zhang,et al.  The correlation of the miR-29a/MMP9 axis with Helicobacter pylori infection in gastric cancer. , 2021, American journal of translational research.

[116]  R. Peek,et al.  DNA Transfer and Toll-like Receptor Modulation by Helicobacter pylori. , 2017, Current topics in microbiology and immunology.

[117]  K. Syrjänen,et al.  Stomach-specific Biomarkers (GastroPanel) Can Predict the Development of Gastric Cancer in a Caucasian Population: A Longitudinal Nested Case-Control Study in Siberia. , 2016, Anticancer research.

[118]  R. Peek,et al.  Pathobiology of Helicobacter pylori-Induced Gastric Cancer. , 2016, Gastroenterology.

[119]  M. Gubina,et al.  The immune response to Helicobacter pylori. , 2014 .

[120]  S. Çam,et al.  Risk of gastric cancer in children with Helicobacter pylori infection. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[121]  T. Wang,et al.  Lack of commensal flora in Helicobacter pylori-infected INS-GAS mice reduces gastritis and delays intraepithelial neoplasia. , 2011, Gastroenterology.